This content provides drug business developed by KYORIN Pharmaceutical, KYORIN Rimedio and KYORIN Pharmaceutical Group Facility.
New Drugs: Drug Discovery and Development
KYORIN Pharmaceutical is strengthening drug discovery capability to create high-value new drugs that meet medical needs.
New Drugs: In-Licensing
KYORIN Pharmaceutical will generate stable earnings and create new business opportunities by stabilizing our existing alliances and creating new business.
New Drugs: Marketing
KYORIN Pharmaceutical’s business strategies plan include a shift to solution-based pharmaceutical marketing and the accelerated growth of the new drugs.
Infectious related products
We offer information and proposal for resolving issues related to infectious disease and infection control from multifaceted perspective encompassing prevention, diagnosis, and treatment to medical professionals.
Kyorin Group is working to provides safe and secure over-the-counter drugs response to diversifying healthcare needs.
KYORIN Rimedio is the core company for the Kyorin Group’s generic drugs business. Taking advantage of having development, manufacturing, and sales functions within the KYORIN Group, we are proactively engaged in the field of authorized generics as a new drug-related generic company.
KYORIN Pharmaceutical Group Facilities provides stable supplies of highly reliable products with an awareness of low-cost operations, having three plants as manufacturing centers by giving unique capabilities for overall optimization of all manufactured products and appropriate capital investment.